Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.20.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 12,798 $ 12,123
Premium and trade receivables 10,339 6,247
Short-term investments 1,558 863
Other current assets 2,127 1,090
Total current assets 26,822 20,323
Long-term investments 10,231 7,717
Restricted deposits 1,050 658
Property, software and equipment, net 2,544 2,121
Goodwill 17,434 6,863
Intangible assets, net 8,702 2,063
Other long-term assets 1,564 1,249
Total assets 68,347 40,994
Current liabilities:    
Medical claims liability 11,418 7,473
Accounts payable and accrued expenses 8,704 4,164
Return of premium payable 1,242 824
Unearned revenue 448 383
Current portion of long-term debt 106 88
Total current liabilities 21,918 12,932
Long-term debt 16,708 13,638
Other long-term liabilities 4,516 1,732
Total liabilities 43,142 28,302
Commitments and contingencies
Redeemable noncontrolling interests 33 33
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 595,160 issued and 579,345 outstanding at June 30, 2020, and 421,508 issued and 415,048 outstanding at December 31, 2019 0 0
Additional paid-in capital 19,333 7,647
Accumulated other comprehensive earnings 245 134
Retained earnings 6,236 4,984
Treasury stock, at cost (15,815 and 6,460 shares, respectively) (758) (214)
Total Centene stockholders’ equity 25,056 12,551
Nonredeemable Noncontrolling interest 116 108
Total stockholders’ equity 25,172 12,659
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 68,347 $ 40,994